drugset / Trial / NCT05754801

Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer

NCT05754801 ↗

Phase 2 Not yet recruiting 172 enrolled Chinese University of Hong Kong
RandomizedParallel-groupTriple-blindSupportive care

Summary

A randomized, double-blinded, placebo-controlled clinical trial using a Chinese Medicine 'Coriolus Versicolor for improving the quality of life of patients with advanced-stage cancer. Subjects will be randomized into a treatment group or placebo group for 6 months.

Timeline

Start
2023-04-01
Primary completion
2026-03-31
Completion
2026-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Yunzhi Essence Traditional medicine (herbal / TCM) — —

Indications